CAR-T engineering of patients’ own T cells for cancer therapy gains traction – Genetic Literacy Project
Genetic Literacy Project |
CAR-T engineering of patients' own T cells for cancer therapy gains traction
Genetic Literacy Project First, Gilead Sciences of Foster City, California, announced plans on August 28 to dole out $11.9 billion to acquire Santa Monica, California–based Kite Pharma, one of the leading developers of chimeric antigen receptor (CAR)-T cell immunotherapies … |
